Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid Desaturases | 10 | 2020 | 51 | 1.720 |
Why?
|
| gamma-Linolenic Acid | 3 | 2020 | 11 | 1.200 |
Why?
|
| Linoleic Acid | 5 | 2020 | 19 | 0.910 |
Why?
|
| Neutrophils | 4 | 2014 | 120 | 0.720 |
Why?
|
| Plant Oils | 2 | 2020 | 17 | 0.720 |
Why?
|
| Lipids | 5 | 2020 | 250 | 0.660 |
Why?
|
| Phospholipids | 2 | 2014 | 32 | 0.650 |
Why?
|
| Soybean Oil | 1 | 2020 | 9 | 0.630 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2020 | 1052 | 0.630 |
Why?
|
| Multigene Family | 7 | 2017 | 51 | 0.580 |
Why?
|
| Eicosanoids | 2 | 2016 | 9 | 0.580 |
Why?
|
| Arachidonic Acid | 5 | 2015 | 39 | 0.530 |
Why?
|
| Fatty Acids | 2 | 2015 | 100 | 0.520 |
Why?
|
| Fatty Acids, Omega-6 | 6 | 2017 | 36 | 0.440 |
Why?
|
| Inflammation | 4 | 2017 | 500 | 0.440 |
Why?
|
| Fish Oils | 2 | 2014 | 38 | 0.440 |
Why?
|
| Fatty Acids, Unsaturated | 5 | 2020 | 43 | 0.430 |
Why?
|
| Lipid Metabolism | 1 | 2014 | 104 | 0.390 |
Why?
|
| European Continental Ancestry Group | 7 | 2020 | 1076 | 0.360 |
Why?
|
| DNA Methylation | 3 | 2018 | 144 | 0.340 |
Why?
|
| Dietary Supplements | 4 | 2017 | 187 | 0.340 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 28 | 0.330 |
Why?
|
| Diastole | 1 | 2011 | 98 | 0.330 |
Why?
|
| Memory | 1 | 2011 | 202 | 0.290 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 4 | 2020 | 14 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 1436 | 0.250 |
Why?
|
| Fatty Acids, Omega-3 | 4 | 2017 | 69 | 0.250 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 21 | 0.250 |
Why?
|
| Humans | 23 | 2020 | 32284 | 0.240 |
Why?
|
| African Americans | 5 | 2017 | 1335 | 0.220 |
Why?
|
| Aging | 1 | 2011 | 941 | 0.210 |
Why?
|
| Brain | 1 | 2011 | 966 | 0.210 |
Why?
|
| Middle Aged | 10 | 2020 | 11843 | 0.200 |
Why?
|
| Cholesterol | 3 | 2015 | 258 | 0.200 |
Why?
|
| Male | 11 | 2020 | 19434 | 0.190 |
Why?
|
| Aged | 7 | 2020 | 10257 | 0.180 |
Why?
|
| Animals | 9 | 2016 | 8165 | 0.180 |
Why?
|
| Adult | 8 | 2020 | 9263 | 0.180 |
Why?
|
| Group IV Phospholipases A2 | 2 | 2014 | 6 | 0.170 |
Why?
|
| Genotype | 2 | 2020 | 706 | 0.170 |
Why?
|
| Chromatography, Thin Layer | 2 | 2014 | 9 | 0.170 |
Why?
|
| Phospholipase D | 2 | 2014 | 6 | 0.170 |
Why?
|
| Type C Phospholipases | 2 | 2014 | 8 | 0.160 |
Why?
|
| Female | 11 | 2020 | 19954 | 0.160 |
Why?
|
| Double-Blind Method | 1 | 2020 | 566 | 0.140 |
Why?
|
| Saliva | 1 | 2018 | 41 | 0.130 |
Why?
|
| Mutation | 3 | 2009 | 497 | 0.130 |
Why?
|
| Young Adult | 3 | 2020 | 2652 | 0.130 |
Why?
|
| Leukocytes | 1 | 2018 | 59 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 58 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2017 | 25 | 0.130 |
Why?
|
| Cholesterol, HDL | 2 | 2015 | 181 | 0.130 |
Why?
|
| Gene Frequency | 3 | 2012 | 212 | 0.130 |
Why?
|
| Stearic Acids | 1 | 2015 | 5 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2020 | 1840 | 0.120 |
Why?
|
| Diet | 2 | 2017 | 382 | 0.120 |
Why?
|
| Liver | 2 | 2015 | 491 | 0.120 |
Why?
|
| Docosahexaenoic Acids | 1 | 2015 | 25 | 0.120 |
Why?
|
| Temporal Lobe | 1 | 2015 | 33 | 0.110 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 107 | 0.110 |
Why?
|
| Eicosapentaenoic Acid | 2 | 2013 | 33 | 0.110 |
Why?
|
| United States | 2 | 2015 | 4079 | 0.110 |
Why?
|
| Corn Oil | 1 | 2014 | 4 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 170 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2016 | 252 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2015 | 863 | 0.110 |
Why?
|
| Linkage Disequilibrium | 2 | 2014 | 181 | 0.110 |
Why?
|
| Triglycerides | 1 | 2015 | 234 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2020 | 2320 | 0.110 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 2011 | 15 | 0.110 |
Why?
|
| Overweight | 1 | 2015 | 252 | 0.100 |
Why?
|
| Leukotrienes | 1 | 2013 | 3 | 0.100 |
Why?
|
| Echium | 1 | 2013 | 11 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2014 | 133 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 42 | 0.090 |
Why?
|
| Body Weight | 2 | 2011 | 323 | 0.090 |
Why?
|
| Adaptation, Physiological | 1 | 2012 | 54 | 0.090 |
Why?
|
| Phagocytosis | 1 | 2011 | 19 | 0.090 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2011 | 11 | 0.090 |
Why?
|
| Pseudomonas Infections | 1 | 2011 | 17 | 0.090 |
Why?
|
| Siblings | 1 | 2011 | 23 | 0.090 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 40 | 0.090 |
Why?
|
| alpha-Linolenic Acid | 3 | 2017 | 12 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 489 | 0.080 |
Why?
|
| African Continental Ancestry Group | 1 | 2012 | 338 | 0.080 |
Why?
|
| Encephalitis | 1 | 2011 | 3 | 0.080 |
Why?
|
| Asthma | 1 | 2013 | 262 | 0.080 |
Why?
|
| Family Health | 1 | 2011 | 73 | 0.080 |
Why?
|
| Cell Count | 1 | 2011 | 50 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 146 | 0.080 |
Why?
|
| Vision, Ocular | 1 | 2011 | 33 | 0.080 |
Why?
|
| Risk Factors | 2 | 2015 | 3938 | 0.080 |
Why?
|
| Organ Size | 1 | 2011 | 221 | 0.080 |
Why?
|
| Geography | 1 | 2010 | 30 | 0.080 |
Why?
|
| Genetics, Population | 1 | 2010 | 31 | 0.080 |
Why?
|
| Community Health Services | 1 | 2010 | 47 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2014 | 716 | 0.080 |
Why?
|
| Threonine | 1 | 2009 | 11 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2010 | 98 | 0.080 |
Why?
|
| Diet, Reducing | 1 | 2010 | 85 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 544 | 0.070 |
Why?
|
| Hippocampus | 1 | 2011 | 216 | 0.070 |
Why?
|
| X Chromosome Inactivation | 1 | 2008 | 7 | 0.070 |
Why?
|
| Motor Activity | 1 | 2011 | 332 | 0.070 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2008 | 6 | 0.070 |
Why?
|
| Phosphatidylinositols | 1 | 2008 | 6 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2008 | 9 | 0.070 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 25 | 0.070 |
Why?
|
| Exercise Therapy | 1 | 2010 | 249 | 0.070 |
Why?
|
| Membrane Glycoproteins | 1 | 2008 | 112 | 0.070 |
Why?
|
| Health Promotion | 1 | 2010 | 242 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 52 | 0.070 |
Why?
|
| Depression | 1 | 2011 | 427 | 0.070 |
Why?
|
| Phospholipases A2 | 1 | 2007 | 24 | 0.060 |
Why?
|
| Cognition | 1 | 2011 | 548 | 0.060 |
Why?
|
| Rats | 1 | 2011 | 1892 | 0.060 |
Why?
|
| Alleles | 2 | 2018 | 250 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2018 | 24 | 0.060 |
Why?
|
| Models, Biological | 1 | 2007 | 403 | 0.050 |
Why?
|
| Obesity | 1 | 2010 | 1108 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2011 | 152 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1073 | 0.040 |
Why?
|
| Protein Binding | 2 | 2009 | 243 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2018 | 79 | 0.030 |
Why?
|
| CpG Islands | 1 | 2017 | 44 | 0.030 |
Why?
|
| Demography | 1 | 2017 | 101 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 135 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2017 | 73 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 2015 | 28 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2014 | 3410 | 0.030 |
Why?
|
| Leukotriene B4 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 17 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 192 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 96 | 0.030 |
Why?
|
| Seeds | 1 | 2013 | 11 | 0.030 |
Why?
|
| Adolescent | 2 | 2013 | 3521 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 54 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2014 | 128 | 0.020 |
Why?
|
| Africa | 1 | 2012 | 26 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2014 | 484 | 0.020 |
Why?
|
| Complement C5 | 1 | 2011 | 2 | 0.020 |
Why?
|
| Complement C7 | 1 | 2011 | 2 | 0.020 |
Why?
|
| Opsonin Proteins | 1 | 2011 | 6 | 0.020 |
Why?
|
| Complement C3 | 1 | 2011 | 11 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2011 | 25 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 821 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 99 | 0.020 |
Why?
|
| Protestantism | 1 | 2010 | 6 | 0.020 |
Why?
|
| Directive Counseling | 1 | 2010 | 19 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2010 | 67 | 0.020 |
Why?
|
| Lipoylation | 1 | 2009 | 4 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2009 | 5 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2009 | 10 | 0.020 |
Why?
|
| Cricetulus | 1 | 2009 | 21 | 0.020 |
Why?
|
| CHO Cells | 1 | 2009 | 27 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 49 | 0.020 |
Why?
|
| Lung | 1 | 2011 | 264 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 2009 | 45 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 248 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2011 | 299 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2011 | 542 | 0.020 |
Why?
|
| Cytochrome b Group | 1 | 2008 | 5 | 0.020 |
Why?
|
| Introns | 1 | 2008 | 40 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2008 | 16 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2008 | 17 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2008 | 39 | 0.020 |
Why?
|
| Glycine | 1 | 2008 | 26 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 77 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 113 | 0.020 |
Why?
|
| Liposomes | 1 | 2008 | 35 | 0.020 |
Why?
|
| Organelles | 1 | 2008 | 4 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2008 | 10 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2008 | 93 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 73 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 80 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 293 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 368 | 0.020 |
Why?
|
| Cell Line | 1 | 2008 | 443 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 1159 | 0.020 |
Why?
|
| Calcium | 1 | 2008 | 337 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 2544 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 2196 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2238 | 0.010 |
Why?
|